Exhibits
10-K
from 10-K 148 pages 10-K
03/14/23
EX-10.23
from 10-K 9 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Not Material and Would Likely Cause Competitive Harm to Sigilon Therapeutics, Inc. if Publicly Disclosed. ​ Consulting Agreement [May Orfali, MD, Mba]
03/14/23
EX-10.24
from 10-K 16 pages ​ ​ ​ ​ ​ ​ February 10, 2023 ​ by Hand & Electronic Delivery ​ May Orfali, M.D. ​ Dear May: ​
03/14/23
EX-10.26
from 10-K 6 pages ​ ​ ​ ​ ​ ​ January 12, 2022 via Electronic Mail ​ Qing Sarah Yuan, PH.D. ​ Dear Sarah, on Behalf of Sigilon Therapeutics, Inc. (The “Company”), I Am Delighted to Make This Conditional Offer of Employment With the Company. This Offer Letter (The “Offer Letter”) and the Accompanying Documents and Agreements Summarize and Set Forth Important Terms About Your Employment With the Company. 1. Starting Date, Position, and Duties. ​
03/14/23
EX-10.27
from 10-K 2 pages ​ ​ ​ ​ ​ ​ October 23, 2019 ​ Josias Fantato De Pontes ​ ​ Re: Employment by Sigilon, Inc. ​ ​ Dear Josias: ​
03/14/23
EX-10.36
from 10-K 4 pages Sigilon Therapeutics, Inc. 2020 Equity Incentive Plan Restricted Stock Unit Agreement
03/14/23
EX-21.1
from 10-K 1 page Subsidiaries of the registrant
03/14/23
EX-23.1
from 10-K 1 page Consent of expert or counsel
03/14/23
EX-31.1
from 10-K ~5 pages Management certification of annual or quarterly disclosure
03/14/23
EX-31.2
from 10-K ~5 pages Management certification of annual or quarterly disclosure
03/14/23
EX-32.1
from 10-K 1 page Management certification of financial report
03/14/23
Graphics & Data Files
External Links